AstraZeneca Pharma Ltd.

BSE: 506820 | NSE: ASTRAZEN |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE203A01020 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

AstraZeneca Ph AstraZeneca Pharma Ltd. | BSE 9114.05 -26.80 (-0.29%) | NSE 9075.50 -69.00 (-0.75%) | Trade | Add

BSE Live

Dec 03, 09:26

9114.05 -26.80 (-0.29%)

Volume

AVERAGE VOLUME

5-Day

439

10-Day

519

30-Day

624

Prev. Close

9140.85
Open Price

9140.20

Bid Price (Qty.)
9084.00 (1)
Offer Price (Qty.)
9094.40 (1)

NSE Live

Dec 03, 09:26

9075.50 -69.00 (-0.75%)

Volume

AVERAGE VOLUME

5-Day

5,555

10-Day

7,936

30-Day

11,586

Prev. Close

9144.50
Open Price

9170.00

Bid Price (Qty.)
9075.00 (1)
Offer Price (Qty.)
9092.50 (7)

Financials

Print/Copy to Excel : Go

Balance Sheet of AstraZeneca Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	5.00	5.00	5.00	5.00	5.00
Total Share Capital	5.00	5.00	5.00	5.00	5.00
Reserves and Surplus	765.35	706.92	583.69	506.39	451.17
Total Reserves and Surplus	765.35	706.92	583.69	506.39	451.17
Total Shareholders Funds	770.35	711.92	588.69	511.39	456.17
NON-CURRENT LIABILITIES
Long Term Borrowings	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liabilities [Net]	0.00	0.00	0.00	0.00	0.00
Other Long Term Liabilities	38.45	2.78	3.69	5.02	8.63
Long Term Provisions	6.32	6.21	8.56	7.50	6.41
Total Non-Current Liabilities	44.77	8.99	12.25	12.52	15.04
CURRENT LIABILITIES
Short Term Borrowings	0.00	0.00	0.00	0.00	0.00
Trade Payables	456.30	196.51	227.88	188.06	178.37
Other Current Liabilities	140.17	117.19	114.37	104.42	88.21
Short Term Provisions	106.53	43.42	41.68	40.17	36.92
Total Current Liabilities	703.00	357.12	383.93	332.65	303.50
Total Capital And Liabilities	1,518.12	1,078.03	984.87	856.56	774.71
ASSETS
NON-CURRENT ASSETS
Tangible Assets	63.58	64.57	68.86	74.49	80.96
Intangible Assets	0.66	2.11	0.00	0.00	0.00
Capital Work-In-Progress	0.00	0.27	1.33	2.20	4.02
Other Assets	0.00	0.00	0.00	0.00	0.00
Fixed Assets	64.24	66.95	70.19	76.69	84.98
Non-Current Investments	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets [Net]	41.56	21.25	20.67	16.30	14.53
Long Term Loans And Advances	0.11	0.27	0.88	0.41	4.33
Other Non-Current Assets	69.86	56.85	57.66	57.49	52.11
Total Non-Current Assets	175.77	145.32	149.40	150.89	155.95
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	548.50	227.88	190.21	140.22	159.80
Trade Receivables	184.88	153.13	107.52	85.89	85.19
Cash And Cash Equivalents	536.70	505.84	500.48	448.46	352.35
Short Term Loans And Advances	0.30	0.13	0.08	0.09	0.36
OtherCurrentAssets	71.97	45.73	37.18	31.01	21.06
Total Current Assets	1,342.35	932.71	835.47	705.67	618.76
Total Assets	1,518.12	1,078.03	984.87	856.56	774.71
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	98.51	138.25	132.28	124.60	89.17
CIF VALUE OF IMPORTS
Raw Materials	0.00	0.00	0.00	0.00	0.00
Stores, Spares And Loose Tools	0.00	0.00	0.00	0.00	0.00
Trade/Other Goods	0.00	0.00	0.00	0.00	0.00
Capital Goods	0.00	0.00	0.00	0.00	0.00
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	6.40	6.10	374.70	255.20	238.20
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	--	--	--	--	--
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	--	--	--	--	--
Other Earnings	104.90	109.40	61.20	44.20	31.77
BONUS DETAILS
Bonus Equity Share Capital	2.50	2.50	2.50	2.50	2.50
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	--	--	--	--	--
Non-Current Investments Unquoted Book Value	--	--	--	--	--
CURRENT INVESTMENTS
Current Investments Quoted Market Value	--	--	--	--	--
Current Investments Unquoted Book Value	--	--	--	--	--